Sweden· SE-20181129000097
Esketamine Kalceks 25 mg/ml Injektions-/infusionsvätska, lösning
A medicinal product containing esketamine, registered in Sweden by AS KALCEKS.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Esketamine
- Manufacturer
- AS KALCEKS
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20181129000097
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Esketamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEsketamine KalceksAS Kalceks
- BelgiumEsketamine Kalceks 25 mg/mlKalceks
- SwitzerlandEsketamin Sintetica 25 mg/ml, soluzione iniettabile o per infusioneSintetica SA
- NorwayEsketamin inresaInresa Arzneimittel
- NetherlandsEsketamine 5 mg/ml Focus, oplossing voor injectie / infusieFocus Care Pharmaceuticals B.V.
- GermanyEsketaminInresa Arzneimittel Gmbh
- United KingdomEsketamine 250mg/10ml solution for injection ampoulesSintetica Ltd
- CzechiaSPRAVATOJanssen-Cilag International N.V., Beerse
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Escetex, Eskelan
- Belgium · Esketamine Kalceks, Vesierra
- Germany · Esketamin, Esketamin Inresa
- Denmark · Esketamine Orifarm, S-Ketamin Pfizer
- Estonia · Esketex
- Finland · Esketamine Kalceks, Esketamine Orifarm
- France · Eskesia, Esketamine Renaudin
- United Kingdom (Northern Ireland) · Esketamine Idd, Esketamine Kalceks
- Croatia · Esgamda
- Iceland · S-Ketamin Pfizer, Spravato
- Liechtenstein · Spravato
- Luxembourg · Vesierra
- Latvia · Esketamine Kalceks
- Netherlands · Esketamine Focus, Esketamine Idd
- Norway · Ketanest, Sinmelan
- Slovenia · Esketamin Kalceks, Sinmelan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f569473a-d9cb-4249-b36b-c642ff90ef54 GET /v1/drugs/f569473a-d9cb-4249-b36b-c642ff90ef54?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20181129000097",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20181129000097",
"product_doc_link": "https://docetp.mpa.se/LMF/Esketamine%20Kalceks%20solution%20for%20injection%20or%20infusion%20SmPC_09001bee807a24b9.pdf"
}See everything about esketamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.